Phase I trial of combination of FOLFIRI and pasireotide, a somatostatin analogue, in advanced gastrointestinal malignancies. - Mahipal A; Shibata D; Siegel E; Springett G; Almhanna K; Fulp W; Williams-Elson I; Kim R (Investigational new drugs, 2015)